HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased levels of IFN-gamma in the trigeminal ganglion correlate with protection against HSV-1-induced encephalitis following subcutaneous administration with androstenediol.

Abstract
Androstenediol (AED) is a metabolic product of dehydroepiandrosterone (DHEA), an adrenal steroid known to possess immunomodulatory characteristics. The present study was undertaken to assess the efficacy of AED treatment in mice ocularly infected with herpes simplex virus type 1 (HSV-1). The subcutaneous administration of 320 mg/kg AED 4 h prior to viral inoculation was found to enhance the survival of HSV-1-infected mice while lower doses (32.0-100.0 mg/kg) were without effect. However, there were no apparent differences in the viral load in the eye or trigeminal ganglion (TG) 3 or 6 days post infection (p.i.) in vehicle- or AED (320 mg/kg)-treated mice. Likewise, there were no differences in the expression of cytokine or chemokine mRNAs in the eyes or TG early (i.e., 3 days p.i.) following infection. However, by 6 days p.i., there was a significant increase in the expression of the chemokines IP-10, MCP-1, and RANTES and the cytokines interleukin-6 (IL-6) and interferon-gamma (IFN-gamma) in the AED (320 mg/kg)-treated mice compared to vehicle-treated controls as determined by reverse transcription (RT)-polymerase chain reaction (PCR) and quantitative PCR (for IFN-gamma). Likewise, there was a corresponding increase in IFN-gamma and IL-2 but not IL-12 protein in the TG of AED-treated mice 6 days p.i. AED-treatment also induced a rise in splenic natural killer activity in a dose- and time-dependent fashion. Collectively, these results suggest that the protective effect following subcutaneous administration of AED is associated in a rise in selective type 1 cytokines (IL-2 and IFN-gamma) as well as natural killer activity.
AuthorsD J Carr
JournalJournal of neuroimmunology (J Neuroimmunol) Vol. 89 Issue 1-2 Pg. 160-7 (Aug 14 1998) ISSN: 0165-5728 [Print] Netherlands
PMID9726838 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anabolic Agents
  • Antineoplastic Agents
  • Chemokine CCL2
  • Chemokine CCL5
  • Chemokine CXCL10
  • Chemokines, CXC
  • Cytokines
  • Interleukin-2
  • Interleukin-6
  • Interleukin-12
  • Interferon-gamma
  • Androstenediol
  • Corticosterone
Topics
  • Anabolic Agents (pharmacology)
  • Androstenediol (pharmacology)
  • Animals
  • Antineoplastic Agents (immunology)
  • Chemokine CCL2 (genetics, immunology)
  • Chemokine CCL5 (genetics, immunology)
  • Chemokine CXCL10
  • Chemokines, CXC (immunology)
  • Corticosterone (blood)
  • Cytokines (blood)
  • Encephalitis, Viral (drug therapy, immunology, mortality)
  • Female
  • Flow Cytometry
  • Gene Expression (immunology)
  • Herpes Simplex (drug therapy, immunology, mortality)
  • Herpesvirus 1, Human (immunology)
  • Injections, Subcutaneous
  • Interferon-gamma (genetics, immunology, metabolism)
  • Interleukin-12 (analysis, immunology)
  • Interleukin-2 (analysis, immunology)
  • Interleukin-6 (genetics, immunology)
  • Killer Cells, Natural (immunology, virology)
  • Mice
  • Mice, Inbred ICR
  • Survival Analysis
  • Trigeminal Ganglion (immunology, metabolism, virology)
  • Viral Load

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: